Naomi Allen
BSc, MSc, DPhil
Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is a Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU).
She joined UK Biobank as Senior Epidemiologist in 2011, and became Chief Scientist in 2019, where she is responsible for following-up participants both through linkage with routine health-related datasets, and through web-based questionnaires. She is also involved in developing the scientific strategy for future enhancements for the study.
Her research interest is largely in the role of diet, obesity and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world.
Recent publications
Harmonised Health Outcomes Across Administrative Data: Lessons, Opportunities, and Challenges from UK Biobank
Conference paper
Domzaridou E. et al, (2026)
UK Biobank: Transforming drug discovery and precision medicine.
Journal article
Bešević J. et al, (2026), Br J Pharmacol, 183, 234 - 248
UK Biobank at 20 years old: a growing, global resource for dementia research
Journal article
ALLEN N. et al, (2025), Nature Reviews Neurology
Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition.
Journal article
Smith-Byrne K. et al, (2025), Cancer Epidemiol Biomarkers Prev, 34, 2058 - 2067